Cargando…

PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin‐II by reducing TGF‐β1/Smads pathway activation

Fibrosis serves a critical role in driving atrial remodelling‐mediated atrial fibrillation (AF). Abnormal levels of the transcription factor PU.1, a key regulator of fibrosis, are associated with cardiac injury and dysfunction following acute viral myocarditis. However, the role of PU.1 in atrial fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Juan, Zhang, Jing‐Jing, Li, Li, Wang, Shan‐Ling, Yang, Hai‐Tao, Fan, Xian‐Wei, Zhang, Lei‐Ming, Hu, Guang‐Ling, Fu, Hai‐Xia, Song, Wei‐Feng, Yan, Li‐Jie, Liu, Jing‐Jing, Wu, Jin‐Tao, Kong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278085/ https://www.ncbi.nlm.nih.gov/pubmed/34132026 http://dx.doi.org/10.1111/jcmm.16678

Ejemplares similares

Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway
por: Hai, Zhen, et al.
Publicado: (2023)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
por: Lv, Wenkui, et al.
Publicado: (2020)

Association between complete right bundle branch block and atrial fibrillation development
por: Zhang, Fu‐Tao, et al.
Publicado: (2022)

Effect of catheter ablation on clinical outcomes in patients with atrial fibrillation and significant functional mitral regurgitation
por: Wu, Jin-Tao, et al.
Publicado: (2021)

Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways
por: Wu, Yingbiao, et al.
Publicado: (2023)

Effect of pulmonary vein isolation on atrial fibrillation recurrence after accessory pathway ablation in patients with Wolff‐Parkinson‐White syndrome
por: Wu, Jin‐Tao, et al.
Publicado: (2020)

LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation
por: Cao, Feng, et al.
Publicado: (2019)

Advanced interatrial block predicts recurrence of atrial fibrillation after accessory pathway ablation in patients with Wolff‐Parkinson‐White syndrome
por: Wu, Jin‐Tao, et al.
Publicado: (2019)

Atrial fibrosis underlying atrial fibrillation (Review)
por: Li, Chang Yi, et al.
Publicado: (2021)

Beta-blockers and 1-year clinical outcomes in hospitalized heart failure patients with atrial fibrillation
por: XING, Fu-Wei, et al.
Publicado: (2021)

Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
por: Zhu, Tianyu, et al.
Publicado: (2022)

The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis
por: Wang, Jiangrong, et al.
Publicado: (2019)

Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation
por: Li, Peng-Fei, et al.
Publicado: (2019)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

Predictive value of red cell distribution width on left atrial thrombus or left atrial spontaneous echo contrast in patients with non-valvular atrial fibrillation
por: Zhan, Xian-Zhang, et al.
Publicado: (2018)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Bone Morphogenetic Protein-7 Antagonizes Myocardial Fibrosis Induced by Atrial Fibrillation by Restraining Transforming Growth Factor-β (TGF-β)/Smads Signaling
por: Chen, Xinjun, et al.
Publicado: (2016)

Discharge heart rate and 1-year clinical outcomes in heart failure patients with atrial fibrillation
por: Xing, Fuwei, et al.
Publicado: (2022)

Device-Related Thrombosis in Patients Receiving One-Stop Intervention for Nonvalvular Atrial Fibrillation: A Systemic Review and Meta-Analysis
por: Hu, Li-xing, et al.
Publicado: (2021)

Diagnostic Value of Delayed Contrast-Enhanced Cardiac Computed Tomography for Detecting Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation
por: Li, Xiang-Nan, et al.
Publicado: (2022)

Circular RNA expression profiles of persistent atrial fibrillation in patients with rheumatic heart disease
por: Hu, Miaoyang, et al.
Publicado: (2019)

The Dose-Dependent Effects of Spironolactone on TGF-β1 Expression and the Vulnerability to Atrial Fibrillation in Spontaneously Hypertensive Rats
por: Tang, Mirong, et al.
Publicado: (2021)

Left atrial effective conducting size predicts atrial fibrillation vulnerability in persistent but not paroxysmal atrial fibrillation
por: Williams, Steven E., et al.
Publicado: (2019)

Hydrogen Sulfide Ameliorates Angiotensin II-Induced Atrial Fibrosis Progression to Atrial Fibrillation Through Inhibition of the Warburg Effect and Endoplasmic Reticulum Stress
por: Hu, Heng-Jing, et al.
Publicado: (2021)

Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation
por: Chen, Yu-Yang, et al.
Publicado: (2016)

Role of Caveolin-1 in Atrial Fibrillation as an Anti-Fibrotic Signaling Molecule in Human Atrial Fibroblasts
por: Yi, Shao-lei, et al.
Publicado: (2014)

Reconceptualising Atrial Fibrillation Using Renewal Theory: A Novel Approach to the Assessment of Atrial Fibrillation Dynamics
por: Quah, Jing Xian, et al.
Publicado: (2021)

TGF‐β1 promotes gap junctions formation in chondrocytes via Smad3/Smad4 signalling
por: Wang, Qingxuan, et al.
Publicado: (2018)

Human Epicardial Adipose Tissue cTGF Expression is an Independent Risk Factor for Atrial Fibrillation and Highly Associated with Atrial Fibrosis
por: Wang, Qing, et al.
Publicado: (2018)

Effect of Left Atrial Appendage Closure in Combination With Catheter Ablation on Left Atrial Function for Persistent Atrial Fibrillation
por: Yang, Jing, et al.
Publicado: (2021)

Predictive value of serum uric acid on left atrial spontaneous echo contrast in non-valvular atrial fibrillation patients
por: Liao, Hong-Tao, et al.
Publicado: (2015)

Combined atrial fibrillation ablation and left atrial appendage closure: Watchman vs. LAmbre devices
por: Ke, Jin-Yan, et al.
Publicado: (2022)

CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post‐Myocardial Infarction Rats
por: Liu, Mingxin, et al.
Publicado: (2019)

Correction: Role of Caveolin-1 in Atrial Fibrillation as an Anti-Fibrotic Signaling Molecule in Human Atrial Fibroblasts
por: Yi, Shao-lei, et al.
Publicado: (2019)

Assessment of Atrial Fibrillation and Vulnerability in Patients with Wolff-Parkinson-White Syndrome Using Two-Dimensional Speckle Tracking Echocardiography
por: Li, Jing-Jie, et al.
Publicado: (2014)

Shifts in gut microbiome and metabolome are associated with risk of recurrent atrial fibrillation
por: Li, Jing, et al.
Publicado: (2020)

Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement
por: Hu, Wei, et al.
Publicado: (2020)

Research Progress of Myocardial Fibrosis and Atrial Fibrillation
por: Li, Guangling, et al.
Publicado: (2022)

Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability
por: Li, Biao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8hgapui8te0e062d43qi92i8ld